Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald D Alvarez

Showing results (61-70 of 211) with videos related to

Pageof 22
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2009
Phase II trial of ixabepilone as second-line treatment in advanced endometrial cancer: gynecologic oncology group trial 129-PDon S Dizon, John A Blessing, D Scott McMeekin, et al.
Current Oncology Reports|February 10, 2022
Development of Delivery Systems for Local Administration of Cytokines/Cytokine Gene-Directed Therapeutics: Modern Oncologic ImplicationsJhalak Dholakia, Alexander C Cohen, Charles A Leath, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 23, 2009
Lower risk of cervical intraepithelial neoplasia in women with high plasma folate and sufficient vitamin B12 in the post-folic acid fortification eraChandrika J Piyathilake, Maurizio Macaluso, Ronald D Alvarez, et al.
Gynecologic Oncology|April 7, 2016
Moving beyond the platinum sensitive/resistant paradigm for patients with recurrent ovarian cancerRonald D Alvarez, Ursula A Matulonis, Thomas J Herzog, et al.
Gynecologic Oncology|January 31, 2004
The role of radical parametrectomy in the treatment of occult cervical carcinoma after extrafascial hysterectomyCharles A Leath, J Michael Straughn, Snehal M Bhoola, et al.
Gynecologic Oncology|December 8, 2004
Retrospective analysis of weekly topotecan as salvage therapy in relapsed ovarian cancerSnehal M Bhoola, Robert L Coleman, Thomas Herzog, et al.
Journal of Lower Genital Tract Disease|May 5, 2005
A prospective evaluation of "see and treat" in women with HSIL Pap smear results: is this an appropriate strategy?T Michael Numnum, Tyler O Kirby, Charles A Leath, et al.
American Journal of Obstetrics and Gynecology|January 10, 2019
The American Gynecological and Obstetrical Society-reinvigorating for the 21st centuryLaurel W Rice, Charles J Lockwood, Maureen Phipps, et al.
American Journal of Obstetrics and Gynecology|September 20, 2020
ReplyRonald D Alvarez, Barbara A Goff, David Chelmow, et al.
Oncotarget|August 11, 2016
Crosstalk between the mitochondrial fission protein, Drp1, and the cell cycle is identified across various cancer types and can impact survival of epithelial ovarian cancer patientsDeepak Kumar Tanwar, Danitra J Parker, Priyanka Gupta, et al.
Pageof 22

Showing results (61-70 of 211) with videos related to

Sort By:
Pageof 22
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2009
Phase II trial of ixabepilone as second-line treatment in advanced endometrial cancer: gynecologic oncology group trial 129-PDon S Dizon, John A Blessing, D Scott McMeekin, et al.
Current Oncology Reports|February 10, 2022
Development of Delivery Systems for Local Administration of Cytokines/Cytokine Gene-Directed Therapeutics: Modern Oncologic ImplicationsJhalak Dholakia, Alexander C Cohen, Charles A Leath, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 23, 2009
Lower risk of cervical intraepithelial neoplasia in women with high plasma folate and sufficient vitamin B12 in the post-folic acid fortification eraChandrika J Piyathilake, Maurizio Macaluso, Ronald D Alvarez, et al.
Gynecologic Oncology|April 7, 2016
Moving beyond the platinum sensitive/resistant paradigm for patients with recurrent ovarian cancerRonald D Alvarez, Ursula A Matulonis, Thomas J Herzog, et al.
Gynecologic Oncology|January 31, 2004
The role of radical parametrectomy in the treatment of occult cervical carcinoma after extrafascial hysterectomyCharles A Leath, J Michael Straughn, Snehal M Bhoola, et al.
Gynecologic Oncology|December 8, 2004
Retrospective analysis of weekly topotecan as salvage therapy in relapsed ovarian cancerSnehal M Bhoola, Robert L Coleman, Thomas Herzog, et al.
Journal of Lower Genital Tract Disease|May 5, 2005
A prospective evaluation of "see and treat" in women with HSIL Pap smear results: is this an appropriate strategy?T Michael Numnum, Tyler O Kirby, Charles A Leath, et al.
American Journal of Obstetrics and Gynecology|January 10, 2019
The American Gynecological and Obstetrical Society-reinvigorating for the 21st centuryLaurel W Rice, Charles J Lockwood, Maureen Phipps, et al.
American Journal of Obstetrics and Gynecology|September 20, 2020
ReplyRonald D Alvarez, Barbara A Goff, David Chelmow, et al.
Oncotarget|August 11, 2016
Crosstalk between the mitochondrial fission protein, Drp1, and the cell cycle is identified across various cancer types and can impact survival of epithelial ovarian cancer patientsDeepak Kumar Tanwar, Danitra J Parker, Priyanka Gupta, et al.
Pageof 22